Aurobindo Pharma enters US inhalation market with generic Advair launch
The launch marks Aurobindo Pharma's entry into the US inhalation market and expands its complex generics portfolio beyond conventional oral solid formulations
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.